CME Group Inc. (BVMF:CHME34)

CME Group Statistics

Total Valuation

CME Group has a market cap or net worth of BRL 550.20 billion. The enterprise value is 556.82 billion.

Market Cap	550.20B
Enterprise Value	556.82B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Dec 11, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.12%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	0.29%
Owned by Institutions (%)	90.96%
Float	359.03M

Valuation Ratios

The trailing PE ratio is 27.78 and the forward PE ratio is 24.54.

PE Ratio	27.78
Forward PE	24.54
PS Ratio	16.17
PB Ratio	3.66
P/TBV Ratio	n/a
P/FCF Ratio	25.28
P/OCF Ratio	24.81
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.60, with an EV/FCF ratio of 25.58.

EV / Earnings	28.11
EV / Sales	15.80
EV / EBITDA	20.60
EV / EBIT	22.23
EV / FCF	25.58

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.13.

Current Ratio	1.02
Quick Ratio	0.02
Debt / Equity	0.13
Debt / EBITDA	0.83
Debt / FCF	0.92
Interest Coverage	24.43

Financial Efficiency

Return on equity (ROE) is 13.35% and return on invested capital (ROIC) is 8.13%.

Return on Equity (ROE)	13.35%
Return on Assets (ROA)	1.60%
Return on Invested Capital (ROIC)	8.13%
Return on Capital Employed (ROCE)	11.08%
Revenue Per Employee	9.05M
Profits Per Employee	5.27M
Employee Count	3,760
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, CME Group has paid 5.78 billion in taxes.

Income Tax	5.78B
Effective Tax Rate	22.37%

Stock Price Statistics

The stock price has increased by +0.63% in the last 52 weeks. The beta is 0.29, so CME Group's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	+0.63%
50-Day Moving Average	370.66
200-Day Moving Average	325.59
Relative Strength Index (RSI)	58.35
Average Volume (20 Days)	81

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.57

Income Statement

In the last 12 months, CME Group had revenue of BRL 34.03 billion and earned 19.81 billion in profits. Earnings per share was 55.00.

Revenue	34.03B
Gross Profit	34.03B
Operating Income	22.18B
Pretax Income	25.84B
Net Income	19.81B
EBITDA	23.95B
EBIT	22.18B
Earnings Per Share (EPS)	55.00

Balance Sheet

The company has 13.70 billion in cash and 20.09 billion in debt, giving a net cash position of -6.39 billion.

Cash & Cash Equivalents	13.70B
Total Debt	20.09B
Net Cash	-6.39B
Net Cash Per Share	n/a
Equity (Book Value)	150.24B
Book Value Per Share	417.50
Working Capital	17.13B

Cash Flow

In the last 12 months, operating cash flow was 22.18 billion and capital expenditures -411.43 million, giving a free cash flow of 21.76 billion.

Operating Cash Flow	22.18B
Capital Expenditures	-411.43M
Free Cash Flow	21.76B
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 65.19% and 58.95%.

Gross Margin	100.00%
Operating Margin	65.19%
Pretax Margin	75.94%
Profit Margin	58.95%
EBITDA Margin	70.38%
EBIT Margin	65.19%
FCF Margin	63.96%

Dividends & Yields

This stock pays an annual dividend of 4.64, which amounts to a dividend yield of 1.23%.

Dividend Per Share	4.64
Dividend Yield	1.23%
Dividend Growth (YoY)	-54.72%
Years of Dividend Growth	6
Payout Ratio	103.53%
Buyback Yield	-0.12%
Shareholder Yield	1.11%
Earnings Yield	3.60%
FCF Yield	3.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CME Group has an Altman Z-Score of 0.52 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.52
Piotroski F-Score	4